trial · primary record
Fecal Microbiota Transplant with Pembrolizumab
Melanoma
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2024-09-30 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT03341143 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:11.376Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03341143
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.